Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: A case series and review of the literature

Photodermatology Photoimmunology and Photomedicine

Volumn 28, Issue 2, 2012, Pages 68-79

  Attili, Sasi K ^a   Ibbotson, Sally H ^a   Fleming, Colin ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Actinic keratoses; Basal cell carcinoma; Imiquimod; Periocular; Photodynamic therapy

Indexed keywords

IMIQUIMOD;

ADVERSE OUTCOME; APPLICATION SITE REACTION; ARTICLE; BASAL CELL CARCINOMA; CONJUNCTIVITIS; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; MEDLINE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN INFLAMMATION; SQUAMOUS CELL CARCINOMA; SQUAMOUS INTRAEPIDERMAL CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; EYE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 84858197951     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2011.00640.x     Document Type: Article

References (47)

1. Kleinstein RN, Lehman HF. Incidence and prevalence of eye cancer. Am J Optom Physiol Opt 1977; 54: 49-51.
2. Malhotra R, James CL, Selva D, Huynh N, Huilgol SC. The Australian Mohs database: periocular squamous intraepidermal carcinoma. Ophthalmology 2004; 111: 1925-1929.
3. Cook BE Jr, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology 2001; 108: 2088-2098.
4. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004; 111: 631-636.
5. Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 1993; 38: 169-192.
6. Bernardini FP. Management of malignant and benign eyelid lesions. Curr Opin Ophthalmol 2006; 17: 480-484.
7. Sullivan TJ, Boulton JE, Whitehead KJ. Intraepidermal carcinoma of the eyelid. Clin Experiment Ophthalmol 2002; 30: 23-27.
8. Nemet AY, Deckel Y, Martin PA etal. Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol 2006; 142: 293-297.
9. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years. Ophthalmology 2004; 111: 624-630.
10. Murchison AP, Walrath JD, Washington CV. Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review. Clin Exp Dermatol 2011; 39: 65-83.
11. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007; 156: 793-801.
12. Morton CA, McKenna KE, Rhodes LE. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-1266.
13. Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol 2009; 145: 1431-1438.
14. Attili S, Ibbotson S. How we treat Bowen's disease with topical photodynamic therapy in Dundee. Photodiagnosis Photodyn Ther 2009; 6: 41-45.
15. Oster-Schmidt C, Altmeyer P, Stcker M. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream. Acta Derm Venereol 2002; 82: 477.
16. Carneiro RC, de Macedo EM, Matayoshi S. Imiquimod 5% cream for the treatment of periocular basal cell carcinoma. Ophthal Plast Reconstr Surg 2010; 26: 100-102.
17. Tsang HH, Huynh NT, Hollenbach E. Topical therapy with imiquimod for eyelid lesion. Clin Experiment Ophthalmol 2006; 34: 179-181.
18. Vereecken P, Monsieur E, Petein M, Heenen M. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome. J Dermatolog Treat 2004; 15: 120-121.
19. Blasi MA, Giammaria D, Balestrazzi E. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. Am J Ophthalmol 2005; 140: 1136-1139.
20. Choontanom R, Thanos S, Busse H, Stupp T. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1217-1220.
21. Hengge UR, Stark R. Topical imiquimod to treat intraepidermal carcinoma. Arch Dermatol 2001; 137: 709-711.
22. Leppala J, Kaarniranta K, Uusitalo H, Kontkanen M. Imiquimod in the treatment of eyelid basal cell carcinoma. Acta Ophthalmol Scand 2007; 85: 566-568.
23. Brannan PA, Anderson HK, Kersten RC, Kulwin DR. Bowen disease of the eyelid successfully treated with imiquimod. Ophthal Plast Reconstr Surg 2005; 21: 321-322.
24. Cannon PS, O'Donnell B, Huilgol SC, Selva D. The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions. Br J Ophthalmol 2011; 95: 1682-1685.
25. Gaitanis G, Kalogeropoulos C, Bassukas ID. Imiquimod can be combined with cryosurgery (immunocryosurgery) for locally advanced periocular basal cell carcinomas. Br J Ophthalmol 2011; 95: 890-892.
26. Garcia-Martin E, Idoipe M, Gil LM etal. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas. J Ocul Pharmacol Ther 2010; 26: 373-379.
27. Prokosch V, Thanos S, Spaniol K, Stupp T. Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids. Graefes Arch Clin Exp Ophthalmol 2011; 249: 121-125.
28. Hintschich C, Feyh J, Beyer-Machule C, Riedel K, Ludwig K. Photodynamic laser therapy of basal-cell carcinoma of the lid. Ger J Ophthalmol 1993; 2: 212-217.
29. Hoerauf H, Httmann G, Diddens H, Thiele B, Laqua H. Photodynamic therapy of eyelid basalioma after topical administration of delta-aminolevulinic acid. Ophthalmologe 1994; 91: 824-829.
30. Wang I, Bauer B, Andersson-Engels S, Svanberg S, Svanberg K. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. Acta Ophthalmol Scand 1999; 77: 182-188.
31. Togsverd-Bo K, Haedersdal M, Wulf HC. Photodynamic therapy for tumors on the eyelid margins. Arch Dermatol 2009; 145: 944-947.
32. Puccioni M, Santoro N, Giansanti F etal. Photodynamic therapy using methyl aminolevulinate acid in eyelid basal cell carcinoma: a 5-year follow-up study. Ophthal Plast Reconstr Surg 2009; 25: 115-118.
33. Kotimaki J. Photodynamic therapy of eyelid basal cell carcinoma. J Eur Acad Dermatol Venereol 2009; 23: 1083-1087.
34. Calista D, Coccia L. Photodynamic therapy for the treatment of in situ squamous cell carcinoma of the left eyelid. Int J Dermatol 2008; 47: 1319-1321.
35. Sotiriou E, Apalla Z, Maliamani F, Zaparas N, Panagiotidou D, Ioannides D. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Eur Acad Dermatol Venereol 2009; 23: 1061-1065.
36. Lindgren G, Lark O. Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol 1997; 36: 742-746.
37. Biro L, Price E. Cryosurgical management of basal cell carcinoma of the eyelid: a 10-year experience. J Am Acad Dermatol 1990; 23: 316-317.
38. Gunnarson G, Lark O, Hersle K. Cryosurgery of eyelid basal cell carcinomas. Acta Ophthalmol Scand 1990; 68: 241-245.
39. Moesen I, Duncan M, Cates C etal. Nitrous oxide cryotherapy for primary periocular basal cell carcinoma: outcome at 5 years follow-up. Br J Ophthalmol 2011; 95: 1679-1681.
40. Fraunfelder FT, Zacarian SA, Wingfield DL, Limmer BL. Results of cryotherapy for eyelid malignancies. Am J Ophthalmol 1984; 97: 184-188.
41. Buschmann W. A reappraisal of cryosurgery for eyelid basal cell carcinomas. Br J Ophthalmol 2002; 86: 453-457.
42. Domonkos AN. Treatment of eyelid carcinoma. Arch Dermatol 1965; 91: 364-370.
43. Garcia-Martin E, Gil-Arribas LM, Idoipe M etal. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. Br J Ophthalmol 2011; 95: 1393-1396.
44. Varma S, Holt PJ, Anstey AV. Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. Br J Dermatol 2000; 142: 825-826.
45. Rossi R, Puccioni M, Mavilia L etal. Squamous cell carcinoma of the eyelid treated with photodynamic therapy. J Chemother 2004; 16: 306-309.
46. Procianoy F, Cruz AA, Baccega A, Ferraz V, Chahud F. Aggravation of eyelid and conjunctival malignancies following photodynamic therapy in DeSanctis-Cacchione syndrome. Ophthal Plast Reconstr Surg 2006; 22: 498-499.
47. Schutt F, Staff C, Stein T, Hartschuh W, Dithmar S. Photodynamic therapy of lid basal cell carcinomas in a 13-year-old patient with Gorlin Goltz syndrome. Klin Monatsbl Augenheilkd 2007; 224: 670-673.